MedTrace Logo

Longitudinal Follow-up of Male Soccer Players Prone to Developing CAM Hip Deformity

NCT04418596 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2025-04-11

No results posted yet for this study

Summary

Femoroacetabular impingement (FAI) is a clinical problem in which abnormal contact occurs between the thighbone and the hip socket. In intensive, mostly still young, male athletes, this problem seems to be related to a bony deformity on the head of this thighbone, a so-called CAM. FAI itself gives rise to pain symptoms, but in time can even lead to premature osteoarthritis. However, the cause of a CAM deformity itself, nor how FAI then arises, is insufficiently known. In view of FAI prevention and its better treatment, this project thus tries to better understand the underlying mechanisms. For this purpose, we will combine detailed biomechanical evaluations of specific movement patterns with advanced medical imaging and state of the art clinical evaluations to longitudinally follow up a group with a known high risk of developing a CAM deformity, being young male elite soccer players. Findings within this study will be additionally compared with similar analyses performed in patients with FAI. This research aims to thus form a basis to define novel (sports-specific) training schemes for the prevention of FAI, but also to define the actual treatment and rehabilitation plans in more patient-specific and a better-informed way.

Conditions

  • Femoro Acetabular Impingement
  • CAM

Interventions

RADIATION

bi-planer radiography (EOS), Conventional radiography (Hip+pelvis)

low dose radiation medical imaging to visualise the hip joint and lumbo-pelvic complex specifically.

Sponsors & Collaborators

  • Johnson & Johnson

    collaborator INDUSTRY

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Stijn Ghijselings, M.D. · Universitaire Ziekenhuizen KU Leuven

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2024-05-15
Completion
2024-05-15

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04418596 on ClinicalTrials.gov